We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Achilles Therapeutics PLC | NASDAQ:ACHL | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -1.00% | 0.99 | 0.99 | 0.9993 | 1.00 | 0.9801 | 1.00 | 16,924 | 16:42:19 |
CUSIP No. 00449L102
|
|
(1) Names of reporting persons Point72 Asset Management, L.P.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 1,413,809**
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 1,413,809**
|
|
(9) Aggregate amount beneficially owned by each reporting person
1,413,809**
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 3.6%
|
|
(12) Type of reporting person (see instructions) PN
|
CUSIP No. 00449L102
|
|
(1) Names of reporting persons Point72 Capital Advisors, Inc.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 1,413,809**
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 1,413,809**
|
|
(9) Aggregate amount beneficially owned by each reporting person
1,413,809**
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 3.6%
|
|
(12) Type of reporting person (see instructions) CO
|
CUSIP No. 00449L102
|
|
(1) Names of reporting persons Cubist Systematic Strategies, LLC
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 0
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 0
|
|
(9) Aggregate amount beneficially owned by each reporting person
0
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 0%
|
|
(12) Type of reporting person (see instructions) OO
|
CUSIP No. 00449L102
|
|
(1) Names of reporting persons Steven A. Cohen
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization United States
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 1,413,809**
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 1,413,809**
|
|
(9) Aggregate amount beneficially owned by each reporting person
1,413,809**
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 3.6%
|
|
(12) Type of reporting person (see instructions) IN
|
1 Year Achilles Therapeutics Chart |
1 Month Achilles Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions